An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins

Oliver P. Windram, Brandon Weber, Mohamed A. Jaffer, Edward P. Rybicki, Dionne N. Shepherd, Arvind Varsani

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Development of vaccine strategies against human papillomavirus (HPV), which causes cervical cancer, is a priority. We investigated the use of virus-like particles (VLPs) of the most prevalent type, HPV-16, as carriers of foreign proteins. Green fluorescent protein (GFP) was fused to the N or C terminus of both L1 and L2, with L2 chimeras being co-expressed with native L1. Purified chimaeric VLPs were comparable in size (∼55 nm) to native HPV VLPs. Conformation-specific monoclonal antibodies (Mabs) bound to the VLPs, thereby indicating that they possibly retain their antigenicity. In addition, all of the VLPs encapsidated DNA in the range of 6-8 kb.

Original languageEnglish (US)
Pages (from-to)585-589
Number of pages5
JournalArchives of Virology
Volume153
Issue number3
DOIs
StatePublished - Mar 2008
Externally publishedYes

Fingerprint

Papillomaviridae
Human papillomavirus 16
Capsid Proteins
Protein C
Green Fluorescent Proteins
Virion
Uterine Cervical Neoplasms
Carrier Proteins
Vaccines
Monoclonal Antibodies
DNA

ASJC Scopus subject areas

  • Genetics
  • Applied Microbiology and Biotechnology

Cite this

An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins : N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins. / Windram, Oliver P.; Weber, Brandon; Jaffer, Mohamed A.; Rybicki, Edward P.; Shepherd, Dionne N.; Varsani, Arvind.

In: Archives of Virology, Vol. 153, No. 3, 03.2008, p. 585-589.

Research output: Contribution to journalArticle

@article{5cedce6bba5646bf9f1a0568a465d95c,
title = "An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins",
abstract = "Development of vaccine strategies against human papillomavirus (HPV), which causes cervical cancer, is a priority. We investigated the use of virus-like particles (VLPs) of the most prevalent type, HPV-16, as carriers of foreign proteins. Green fluorescent protein (GFP) was fused to the N or C terminus of both L1 and L2, with L2 chimeras being co-expressed with native L1. Purified chimaeric VLPs were comparable in size (∼55 nm) to native HPV VLPs. Conformation-specific monoclonal antibodies (Mabs) bound to the VLPs, thereby indicating that they possibly retain their antigenicity. In addition, all of the VLPs encapsidated DNA in the range of 6-8 kb.",
author = "Windram, {Oliver P.} and Brandon Weber and Jaffer, {Mohamed A.} and Rybicki, {Edward P.} and Shepherd, {Dionne N.} and Arvind Varsani",
year = "2008",
month = "3",
doi = "10.1007/s00705-007-0025-2",
language = "English (US)",
volume = "153",
pages = "585--589",
journal = "Archives of Virology",
issn = "0304-8608",
publisher = "Springer Wien",
number = "3",

}

TY - JOUR

T1 - An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins

T2 - N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins

AU - Windram, Oliver P.

AU - Weber, Brandon

AU - Jaffer, Mohamed A.

AU - Rybicki, Edward P.

AU - Shepherd, Dionne N.

AU - Varsani, Arvind

PY - 2008/3

Y1 - 2008/3

N2 - Development of vaccine strategies against human papillomavirus (HPV), which causes cervical cancer, is a priority. We investigated the use of virus-like particles (VLPs) of the most prevalent type, HPV-16, as carriers of foreign proteins. Green fluorescent protein (GFP) was fused to the N or C terminus of both L1 and L2, with L2 chimeras being co-expressed with native L1. Purified chimaeric VLPs were comparable in size (∼55 nm) to native HPV VLPs. Conformation-specific monoclonal antibodies (Mabs) bound to the VLPs, thereby indicating that they possibly retain their antigenicity. In addition, all of the VLPs encapsidated DNA in the range of 6-8 kb.

AB - Development of vaccine strategies against human papillomavirus (HPV), which causes cervical cancer, is a priority. We investigated the use of virus-like particles (VLPs) of the most prevalent type, HPV-16, as carriers of foreign proteins. Green fluorescent protein (GFP) was fused to the N or C terminus of both L1 and L2, with L2 chimeras being co-expressed with native L1. Purified chimaeric VLPs were comparable in size (∼55 nm) to native HPV VLPs. Conformation-specific monoclonal antibodies (Mabs) bound to the VLPs, thereby indicating that they possibly retain their antigenicity. In addition, all of the VLPs encapsidated DNA in the range of 6-8 kb.

UR - http://www.scopus.com/inward/record.url?scp=39749180995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749180995&partnerID=8YFLogxK

U2 - 10.1007/s00705-007-0025-2

DO - 10.1007/s00705-007-0025-2

M3 - Article

C2 - 18175039

AN - SCOPUS:39749180995

VL - 153

SP - 585

EP - 589

JO - Archives of Virology

JF - Archives of Virology

SN - 0304-8608

IS - 3

ER -